FRα was found to have a high discriminatory capacity based on the histologic subtype of lung cancer, with one study demonstrating an FRα positivity rate of 74% in adenocarcinomas vs. 13% in squamous cell carcinomas of the lung. This evidence concerns the gene FOLR1 and adenocarcinoma.